Recent updates

What is the meaning of pharmaceutical profiling?

Posted on13 Jan 2021

Comments0

Pharmaceutical profiling assays helps to measure the properties of large numbers of drug candidates at the earliest stages of discovery. It is the is the characterization of the physicochemical and...

Sanofi-kymab-deal: Sanofi’s acquisition of a clinical-stage biopharmaceutical company Kymab

Posted on13 Jan 2021

TagsGlobalpharma sanofi, Kymab, monoclonal antibody, Sanofi

Comments0

Global pharmaceutical company, Sanofi will acquire a clinical-stage biopahrmaceutical company Kymab. Sanofi will acquire Kymab for an upfront payment of approximately $1.1 billion and up to $350 million upon achievement...

Covishield received emergency use authorization in India

Posted on01 Jan 2021

TagsAstraZeneca, Covid vaccine, COVID-19, Covishield, serum institute

Comments0

Covidshield vaccine, developed by AstraZeneca and Oxford University has received for emergency use authorization in India. Drugs Controller General of India (DCGI) has recommended granting emergency use authorisation to AstraZeneca’s...

Glenmark introducing Remogliflozin + Vildagliptin combination first time in India

Posted on30 Dec 2020

TagsGlenmark, PMT in pharma, Remogliflozin etabonate, vildagliptin

Comments0

Glenmark Pharmaceuticals Limited is introducing a fixed dose combination (FDC) of Remogliflozin + Vildagliptin. Remogliflozin is Sodium Glucose Co-Transporter Inhibitor (SGLT2i). Sodium/glucose cotransporter-2 inhibitors (SGLT2i) are a new type of...

Myovant and Pfizer’s $4.2 Billion Deal for Orgovyx

Posted on30 Dec 2020

TagsMyovant, Orgovyx, pfizer, relugolix

Comments0

Myovant Sciences is partnering with Pfizer to develop and commercialize Orgovyx for prostate cancer and women’s health. Orgovyx is the brand of relugolix. Relugolix is a once-daily, oral gonadotropin-release hormone...

UK approves Pfizer-BioNTech’s COVID-19 vaccine. Rollout in week time

Posted on03 Dec 2020

TagsBioNTech, Covid vaccine, pfizer

Comments0

The UK today became the first country to approve the Covid-19 vaccine developed by Pfizer Inc and its German partner BioNTech SE. The vaccine will be available in Britain from...

Telix Pharma to acquire TheraPharm GmbH

Posted on01 Dec 2020

TagsScintec, TheraPharm GmbH

Comments0

Telix Pharmaceuticals announced that it has entered into an agreement with Scintec Diagnostics GmbH (Scintec) to acquire TheraPharm GmbH, a Swiss-German biotechnology company developing innovative diagnostic and therapeutic solutions in...

Case Study: Clinical basis of MHLW approval of Astellas’s Evrenzo to treat anemia of CKD in adult patients not on dialysis

Posted on28 Nov 2020

Comments0

Astellas Pharma Inc. and FibroGen, Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Evrenzo (roxadustat) for the treatment of anemia of chronic kidney disease (CKD) in...

Covid 19 Vaccine development and commercialization status | More than 50 vaccine candidate under development

Posted on28 Nov 2020

Comments0

More than 50 covid-19 vaccine candidate is currently under development. Here you can have the close look into the development status of the vaccine candidate. Click here to view Till...

PostEra codevelopment deal with NeuroLucent for Alzheimer’s disease

Posted on28 Nov 2020

Tagscodevelopment deal in pharma, Drug development, drug development project

Comments0

Biotechnology company PostEra announced a collaboration with NeuroLucent, a Chicago-based company focused on developing novel treatments for Alzheimer’s disease and other dementias. The failure of late-stage clinical trials to uncover...

AbbVie, Eisai received new indication approval for Humira to treat pyoderma gangrenosum

Posted on28 Nov 2020

Tags2015 sales of Humira, humira, pyoderma gangrenosum

Comments0

AbbVie GK and Eisai Co, Ltd announced an approval of additional indication of Humira, a fully human anti-TNFa monoclonal antibody, for the treatment of pyoderma gangrenosum (PG). Humira was granted...

Pfizer submitted application for emergency use of Covid vaccine

Posted on20 Nov 2020

TagsCovid vaccine, COVID-19, vaccine

Comments0

US drugmaker Pfizer Inc, which has developed a vaccine against coronavirus, is now seeking the emergency use tag from the US government for its dosage. Pfizer has said the emergency...

Take Self Competency Test in Esxport Documentation

Posted on20 Nov 2020

Tagsmcqs in pharma export documentation

Comments0

You can take a short and quick competency test on pharmaceutical export.

Insight on VFMCRP, Fresenius Kabi distribution agreement for Veltassa to treat hyperkalemia in China

Posted on20 Nov 2020

TagsChronic Kidney Disease, CKD, Fresenius Kabi, Hyperkalemia, Veltassa, VFMCRP, Vifor Pharma

Comments0

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Fresenius Kabi announced an agreement to develop, register and distribute Veltassa for the treatment of hyperkalemia in the People’s Republic of China....

US FDA grants priority review status to Sanofi’s BLA for avalglucosidase alfa to treat Pompe disease

Posted on20 Nov 2020

Tagsavalglucosidase alfa, Biological License Application, biological products, priority review, Priority Review Designation, USFDA Priority Review

Comments0

The US Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for avalglucosidase alfa for long-term enzyme replacement therapy for the treatment of patients...

Case Study on Gliead’s Blockbuster Veklury – Sales and Strategic Planning

Posted on30 Oct 2020

Tagsgilead, Gilead Sciences, pharma strategic deal, Remdesivir, Strategic deal in pharma, strategic management in pharma, Veklury

Comments0

FDA approved Veklury (remdesivir), the first drug approved to treat COVID-19, for use in adults and pediatric patients 12 years of age and older and weighing at least 40 kg...

Sanofi and Merck to conduct phase 2 trial of THOR-707 in combo with Keytruda

Posted on30 Oct 2020

TagsKEYTRUDA, MSD, Phase 2 trial, Sanofi

Comments0

Sanofi has entered into an agreement with Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the US and Canada) to conduct a phase 2 clinical trial to...

MHRA UK inititated rolling review process of Moderna’s mRNA Covid-19 vaccine

Posted on30 Oct 2020

TagsCOVID-19, EU drug regulatory affairs, Moderna Therapeutics, nCoV-19 vaccine, vaccine

Comments0

Moderna, a biotechnology company, announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom has started the rolling review process of mRNA-1273, the company’s vaccine candidate...

Insight of BioInvent’s licensing deal of anti-FcγRllB antibody BI-1206 to CASI Pharmaceuticals

Posted on28 Oct 2020

Tagsglobal pharma licensing deal, licensing deal in pharma

Comments0

BioInvent licenses anti-FcγRllB antibody BI-1206 to CASI Pharmaceuticals for Greater China region. BioInvent have entered into an exclusive licensing agreement for the development and commercialization of novel anti-FcγRIIB antibody, BI-1206,...

Pfizer’s Hospital Business acquires Arixa Pharma

Posted on24 Oct 2020

Tagsacquisition in pharma, Arixa Pharma, pfizer, Strategic deal in pharma

Comments0

Arixa Pharmaceuticals, a company developing next-generation oral antibiotics for drug-resistant Gram-negative infections announced that Pfizer’s Hospital Business has agreed to acquire Arixa. Why this deal? Arixa’s lead compound, ARX-1796, is...

What is the meaning of pharmaceutical profiling?

Sanofi-kymab-deal: Sanofi’s acquisition of a clinical-stage biopharmaceutical company Kymab

Covishield received emergency use authorization in India

Glenmark introducing Remogliflozin + Vildagliptin combination first time in India

Myovant and Pfizer’s $4.2 Billion Deal for Orgovyx

UK approves Pfizer-BioNTech’s COVID-19 vaccine. Rollout in week time

Telix Pharma to acquire TheraPharm GmbH

Case Study: Clinical basis of MHLW approval of Astellas’s Evrenzo to treat anemia of CKD in adult patients not on dialysis

Covid 19 Vaccine development and commercialization status | More than 50 vaccine candidate under development

PostEra codevelopment deal with NeuroLucent for Alzheimer’s disease

AbbVie, Eisai received new indication approval for Humira to treat pyoderma gangrenosum

Pfizer submitted application for emergency use of Covid vaccine

Take Self Competency Test in Esxport Documentation

Insight on VFMCRP, Fresenius Kabi distribution agreement for Veltassa to treat hyperkalemia in China

US FDA grants priority review status to Sanofi’s BLA for avalglucosidase alfa to treat Pompe disease

Case Study on Gliead’s Blockbuster Veklury – Sales and Strategic Planning

Sanofi and Merck to conduct phase 2 trial of THOR-707 in combo with Keytruda

MHRA UK inititated rolling review process of Moderna’s mRNA Covid-19 vaccine

Insight of BioInvent’s licensing deal of anti-FcγRllB antibody BI-1206 to CASI Pharmaceuticals

Pfizer’s Hospital Business acquires Arixa Pharma

Biopharma Selling Skill Training

Executive Program in Biopharma Business Development and Strategic Management

KPE-C-062 KPE’s Certificate Course in Selling Skills for Medical Representatives

KPE-C-080 Certificate Course in Pharma Business Development & Licensing

KPE-C-079 KPE’s 1 Week Fundamental Training on Drug Discovery to Commercialization Pathway

KPE-C-077 – Fundamental Training on Data Integrity in pharmaceutical and biopharmaceutical industry

KPE-C-064N KPE’s 1 Month Certificate Course in Pharma Sales Management

KPE-C-103 Executive Program in Global Drug Regulatory Affairs [EPGDRA]

KPE-C-075 Fundamental Training on Pharma Marketing Plan Development

KPE-C-074 Fundamental Training on Monoclonal Antibody

KPE-C-073 Fundamental Training on Regulatory Affairs Advance Strategic Planning

KPE-C-072 Fundamental Training on 505B(2) Application Submission

Your form has been submitted

Recent updates

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?

Please sign in first

Not a member?